We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Names Four Antibodies and an Arthritis Drug as Preferred COVID-19 Therapies
EU Names Four Antibodies and an Arthritis Drug as Preferred COVID-19 Therapies
The European Medicines Agency (EMA) has issued a list of five preferred therapeutics for COVID-19 patients, including four monoclonal antibodies and Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib).